The most recent 13F filing with the SEC by Dimensional Fund Advisors LP shows that its holdings in Cardinal Health, Inc. (NYSE:CAH) were boosted by 0.5% during the fourth quarter. The fund owned 2,388,863 shares of CAH stock and bought an additional 12,622 shares during the quarter. This earned the Dimensional Fund Advisors LP a holding ownership of 0.93% of Cardinal Health’s worth which amounted to $183,640,000 at the end of the most recent quarter.
Cardinal Health released its first quarterly earnings report on May 4th and reported earnings per share (EPS) of $1.74 for the said period. This beat the consensus estimate of $1.48 by an impressive $0.26. The company also showed strong revenue growth with reports hitting $50.50 billion during Q1 compared to analysts’ expectations pegged at $49.63 billion.
The healthcare services giant’s strong financial footing was boosted further by an increase in their medical products and pharmaceuticals that saw cost-effective solutions being provided to streamline supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices throughout Q1.
Cardinal Health Inc.’s current fiscal year EPS is estimated to be at an impressive 5.73 according to top equities analysts’ average forecast.
As a renowned industry leader providing customized healthcare solutions powered by advanced technology capabilities that support personalized experiences nurturing speedy recovery rates not just in America but globally – it’s no surprise that CAH has firm grip on financial stability while remaining committed towards its clients’ needs -allowing them access to uninterrupted exceptional care – all while posting outstanding financial figures like those recently reported on May 4th – which re-assures investors that they will undoubtedly soar higher as years progress under their management watchful eye!
[bs_forecast_slider ticker=”CAH”]
Cardinal Health: A Leader in Healthcare Services and Products
Cardinal Health, Inc. is a leading healthcare services and products company that specializes in providing customized solutions to hospitals, clinics, laboratories, and physician offices. The company offers a broad range of medical products and pharmaceuticals along with cost-effective logistical solutions that help enhance supply chain efficiency.
With a market capitalization of over $21.84 billion, Cardinal Health has recently been making headlines due to its noteworthy performance on the stock market. Several hedge funds and institutional investors have increased their holdings in the company by purchasing shares of its stock.
According to reports, BlackRock Inc. raised its holdings in Cardinal Health by 25.9% during the third quarter, becoming one of the largest shareholders with a total of 28,680,859 shares valued at $1,912,437,000 after buying an additional 5,896,875 shares during the last quarter. Other notable investors include State Street Corp (21,802,799 shares worth $1,246,751,000), Invesco Ltd. (6,186052 shares valued at $350,748000), ProShare Advisors LLC(2,,807641) among others which own about 88.93% of the company’s stock.
Shares of Cardinal Health stock on Wednesday opened at $85.80 recording an increase from previous low 50-day moving average price of $77.78 and 200-day moving average price of$77.74.Highlights also show that the firm has a PEG ratio of 1.19 and a beta of 0.74.
Further news coming out from the company states that Cardinal Health will pay dividends to shareholders on Saturday July 15th following reports indicating that it disclosed quarterly dividends’ increments from previously announced amount; increasing dividend payout ratio (DPR) from $0.50 to $0.5006 hence enhancing shareholder value.
Research firms have primarily rated Cardinal Health hold although other firms such as StockNews.com have given it the strong-buy rating. Citigroup initiated coverage and gave a neutral rating while TheStreet gave it an upgrade from ‘d+’ to ‘b-‘. The general average rating based on data from Bloomberg is “Hold,” with an estimated target price of $82.23.
As Cardinal Health continues to rank among top healthcare services companies, investors’ confidence is projected to be boosted due to its excellent ratings and financial performance in recent times.
